INDOUS vs NEAGI: Stock Comparison

INDO US BIOTECH vs NEELAMALAI AGRO INDS. LUpdated 15 Sept 26, 3:00 PM ISTNSE & company filings

NEELAMALAI AGRO INDS. L is the larger company by market capitalisation. INDO US BIOTECH shows a lower P/E, a higher ROE and a higher ROCE, while NEELAMALAI AGRO INDS. L shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDOUS leads 8; NEAGI leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDOUSNEAGI

Valuation lens

What price are you paying?

Market CapContext only
₹160 Cr
₹208 Cr
P/E RatioINDOUS has the lower reading
0x
7.05x
P/B RatioINDOUS has the lower reading
0x
0.63x
EPSNEAGI has the higher reading
₹1.51
₹20.76
Book ValueContext only
₹46.15
₹5,260.88
Dividend YieldNEAGI has the higher reading
0%
0.6%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NEAGI is the larger company
₹208 Cr vs ₹160 Cr
P/E Ratio
INDOUS has a lower P/E
0x vs 7.05x
P/B Ratio
INDOUS has a lower P/B
0x vs 0.63x
EPS
NEAGI has higher earnings per share
₹20.76 vs ₹1.51
Dividend Yield
NEAGI has a higher dividend yield
0.6% vs 0%
Revenue Growth (TTM YoY)
NEAGI has faster revenue growth
0% vs -22%
EPS Growth (TTM YoY)
NEAGI has faster EPS growth
0% vs -47.3%
Qtr Sales Growth
INDOUS has stronger quarterly sales growth
26.75% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDOUSNEAGI
SectorFast Moving Consumer Goods
IndustryOther Agricultural Products

Price

MetricINDOUSNEAGI
Live Price₹78.29₹3,308
Day Change0.06%-3.7%
Volume2,09510
52-Week High₹159₹3,600
52-Week Low₹70₹3,001
Distance from 52W High-50.76%-8.11%

Valuation

MetricINDOUSNEAGI
Market Cap₹160 Cr₹208 Cr
P/E Ratio0x7.05x
P/B Ratio0x0.63x
EPS₹1.51₹20.76
Book Value₹46.15₹5,260.88
Dividend Yield0%0.6%

Growth

MetricINDOUSNEAGI
Revenue Growth (TTM YoY)-22%0%
EPS Growth (TTM YoY)-47.3%0%
Qtr Sales Growth26.75%0%
Qtr Profit Growth54.05%-91.58%

Profitability & Leverage

MetricINDOUSNEAGI
ROE14.18%3.51%
ROCE12.34%3.54%
Net Margin11.88%0%
Operating Margin14.64%14.05%
Debt to Equity0.4x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDOUSNEAGI
Promoter Holding68.29%72.45%
FII Holding0.01% 0.17 pp0%
DII Holding0.6%
Public Holding31.7% 0.17 pp26.95%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDO US BIOTECH and NEELAMALAI AGRO INDS. L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.